1 – 5 of 5
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2012
-
Mark
First-line treatment of advanced ovarian cancer with paclitaxel/carboplatin with or without epirubicin (TEC versus TC)-a gynecologic cancer intergroup study of the NSGO, EORTC GCG and NCIC CTG
(
- Contribution to journal › Article
- 2005
-
Mark
Clinical trials in ovarian carcinoma : study methodology
2005) In Annals of oncology : official journal of the European Society for Medical Oncology 16(Suppl 8). p.20-29(
- Contribution to journal › Article
-
Mark
3rd International Ovarian Cancer Consensus Conference : outstanding issues for future consideration
2005) In Annals of oncology : official journal of the European Society for Medical Oncology 16(Suppl 8). p.36-38(
- Contribution to journal › Article
-
Mark
2004 consensus statements on the management of ovarian cancer : final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004)
2005) In Annals of oncology : official journal of the European Society for Medical Oncology 16 Suppl 8. p.7-12(
- Contribution to journal › Article
- 2003
-
Mark
First-line treatment of ovarian cancer FIGO stages IIb-IV with paclitaxel/epirubicin/carboplatin versus paclitaxel/carboplatin
(
- Contribution to journal › Article